Literature DB >> 3800906

A fragment of antithrombin that binds both heparin and thrombin.

L Rosenfeld, I Danishefsky.   

Abstract

In order to identify the regions of antithrombin that interact with heparin and thrombin, it was degraded with CNBr and the activities of the isolated products were investigated. These fragments did not exhibit direct thrombin-neutralizing activity; however, one unique fragment was found to bind to heparin-Sepharose and also to interfere with the inhibition of thrombin by intact antithrombin. This fragment was identified as the one consisting of three disulphide-linked polypeptide chains containing residues 1-17, 104-251 and 424-432. At a concentration of 46 nM, this product decreased the heparin-enhanced thrombin-inhibitory activity of antithrombin by half, and completely abolished this inhibition when above 300 nM. In the absence of heparin, the action of antithrombin was not completely nullified by the fragment, even when present at relatively high concentrations. At a given fragment concentration, the extent of inhibition was independent of antithrombin concentration over the range tested. It was found that the fragment decreased the second-order rate constant for the antithrombin-thrombin reaction. Reduction and alkylation of the fragment showed that the above properties reside primarily in the peptide with residues 104-251. It is concluded that this peptide possesses portions of the antithrombin molecule that bind to heparin as well as to a site on thrombin.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3800906      PMCID: PMC1147039          DOI: 10.1042/bj2370639

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  37 in total

1.  Location on heparin of the oligosaccharide section essential for anticoagulant activity.

Authors:  S Radoff; I Danishefsky
Journal:  J Biol Chem       Date:  1984-01-10       Impact factor: 5.157

2.  Involvement of heparin chain length in the heparin-catalyzed inhibition of thrombin by antithrombin III.

Authors:  M Hoylaerts; W G Owen; D Collen
Journal:  J Biol Chem       Date:  1984-05-10       Impact factor: 5.157

Review 3.  Human plasma proteinase inhibitors.

Authors:  J Travis; G S Salvesen
Journal:  Annu Rev Biochem       Date:  1983       Impact factor: 23.643

4.  Isolation and sequence characterization of a cDNA clone of human antithrombin III.

Authors:  T Chandra; R Stackhouse; V J Kidd; S L Woo
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

5.  Pyridoxylation of essential lysines in the heparin-binding site of antithrombin III.

Authors:  J M Pecon; M N Blackburn
Journal:  J Biol Chem       Date:  1984-01-25       Impact factor: 5.157

6.  Effects of enzymatic deglycosylation on the biological activities of human thrombin and antithrombin.

Authors:  L Rosenfeld; I Danishefsky
Journal:  Arch Biochem Biophys       Date:  1984-02-15       Impact factor: 4.013

7.  The heparin-binding site of antithrombin III. Identification of a critical tryptophan in the amino acid sequence.

Authors:  M N Blackburn; R L Smith; J Carson; C C Sibley
Journal:  J Biol Chem       Date:  1984-01-25       Impact factor: 5.157

8.  Predictions of the secondary structure of antithrombin III and the location of the heparin-binding site.

Authors:  G B Villanueva
Journal:  J Biol Chem       Date:  1984-02-25       Impact factor: 5.157

9.  Antithrombin III Toyama: replacement of arginine-47 by cysteine in hereditary abnormal antithrombin III that lacks heparin-binding ability.

Authors:  T Koide; S Odani; K Takahashi; T Ono; N Sakuragawa
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

10.  The role of tryptophan residues in heparin-antithrombin interactions.

Authors:  G I Karp; J A Marcum; R D Rosenberg
Journal:  Arch Biochem Biophys       Date:  1984-09       Impact factor: 4.013

View more
  2 in total

1.  Re-formation of disulphide bonds in reduced antithrombin III.

Authors:  X J Sun; J Y Chang
Journal:  Biochem J       Date:  1990-08-01       Impact factor: 3.857

2.  Effect of heparin on the glia-derived-nexin-thrombin interaction.

Authors:  A Wallace; G Rovelli; J Hofsteenge; S R Stone
Journal:  Biochem J       Date:  1989-01-01       Impact factor: 3.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.